Literature DB >> 33049489

A simplified critical illness severity scoring system (CISSS): Development and internal validation.

Spyridon Fortis1, Amy M J O'Shea2, Brice F Beck Mae3, Rajeshwari Nair2, Michihiko Goto4, Gregory A Schmidt5, Peter J Kaboli2, Eli N Perencevich2, Heather Schacht Reisinger2, Mary Vaughan Sarrazin2.   

Abstract

PURPOSE: To create a simplified critical illness severity scoring system with high prediction accuracy for 30-day mortality using only commonly available variables.
MATERIALS AND METHODS: This is a retrospective cohort study of ICU admissions 2010-2015 in 306 ICUs in 117 Veterans Affairs (VA) hospitals. We randomly divided our cohort into a training dataset (75%) and a validation dataset (25%). We created a critical illness severity scoring system (CISSS) using age, comorbidities, heart rate, mean arterial blood pressure, temperature, respiratory rate, hematocrit, white blood cell count, creatinine, sodium, glucose, albumin, bilirubin, bicarbonate, use of invasive mechanical ventilation, and whether the admission was surgical or not. We validated the performance of CISSS to predict 30-day mortality internally.
RESULTS: After excluding 31,743 re-admissions, we divided our sample (n = 534,001) into a training (n = 400,613) and a validation dataset (n = 133,388). In the training dataset, the area under the curve (AUC) of CISSS was 0.847(95%CI = 0.845-0.850). In the validation dataset, the AUC was 0.848 (95%CI = 0.844-0.852), the standardized mortality ratio (SMR) was 1.00 (95%CI = 0.98-1.02), and Brier's score for 30-day mortality was 0.058 (95%CI = 0.057-0.059). CISSS calibration was acceptable.
CONCLUSIONS: CISSS has very good performance and requires only commonly used variables that can be easily extracted by electronic health records. Published by Elsevier Inc.

Entities:  

Keywords:  APACHE; Automated; Computerized; Illness severity score; Intensive care units; Mortality

Year:  2020        PMID: 33049489     DOI: 10.1016/j.jcrc.2020.09.029

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  5 in total

Review 1.  Hypoalbuminemia as Surrogate and Culprit of Infections.

Authors:  Christian J Wiedermann
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

2.  Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.

Authors:  Spyridon Fortis; Alejandro P Comellas; Surya P Bhatt; Eric A Hoffman; MeiLan K Han; Nirav R Bhakta; Robert Paine; Bonnie Ronish; Richard E Kanner; Mark Dransfield; Daniel Hoesterey; Russell G Buhr; R Graham Barr; Brett Dolezal; Victor E Ortega; M Bradley Drummond; Mehrdad Arjomandi; Robert J Kaner; Victor Kim; Jeffrey L Curtis; Russell P Bowler; Fernando Martinez; Wassim W Labaki; Christopher B Cooper; Wanda K O'Neal; Gerald Criner; Nadia N Hansel; Jerry A Krishnan; Prescott Woodruff; David Couper; Donald Tashkin; Igor Barjaktarevic
Journal:  Chest       Date:  2021-02-01       Impact factor: 10.262

3.  Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area.

Authors:  Amol A Verma; Tejasvi Hora; Hae Young Jung; Michael Fralick; Sarah L Malecki; Lauren Lapointe-Shaw; Adina Weinerman; Terence Tang; Janice L Kwan; Jessica J Liu; Shail Rawal; Timothy C Y Chan; Angela M Cheung; Laura C Rosella; Marzyeh Ghassemi; Margaret Herridge; Muhammad Mamdani; Fahad Razak
Journal:  CMAJ       Date:  2021-02-10       Impact factor: 8.262

4.  Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry.

Authors:  Spyridon Fortis; Emily S Wan; Ken Kunisaki; Patrick Tel Eyck; Zuhair K Ballas; Russell P Bowler; James D Crapo; John E Hokanson; Chris Wendt; Edwin K Silverman; Alejandro P Comellas
Journal:  Respir Med X       Date:  2020-12-29

5. 

Authors:  Amol A Verma; Tejasvi Hora; Hae Young Jung; Michael Fralick; Sarah L Malecki; Lauren Lapointe-Shaw; Adina Weinerman; Terence Tang; Janice L Kwan; Jessica J Liu; Shail Rawal; Timothy C Y Chan; Angela M Cheung; Laura C Rosella; Marzyeh Ghassemi; Margaret Herridge; Muhammad Mamdani; Fahad Razak
Journal:  CMAJ       Date:  2021-06-07       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.